Not finding it? Sign in to also search OpenAlex live.
-
The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone
Anne-Sophie C A M Koning, Djaina Satoer, Christiaan H. Vinkers, Amir H. Zamanipoor Najafabadi, Nienke Ruurdje Biermasz, Rishi Nandoe Tewarie, +6 more
7citations -
The phenotype of adverse drug effects: Do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study2020 British Journal of Clinical Pharmacology article Medicine Pharmaceutical Practices and Patient Outcomes Open access
Katja Susanne Just, Harald Dormann, Marlen Schurig, Miriam Böhme, Michael Steffens, Bettina Plank‐Kiegele, +8 more
34citations -
Descriptive analysis of 179 German reports of melanoma reported to an adverse drug reaction database as a drug-related adverse effect, and comparison with melanoma cases contained in German cancer registries2022 Clinical and Experimental Dermatology article Medicine Cutaneous Melanoma Detection and Management Open access
Bernhardt Sachs, Diana Dubrall, Klaus Kraywinkel, Maike Schulz, Matthias C. Schmid, Jens Bate, +1 more
1citations -
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
José Tuñón, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, +11 more
76citations -
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes2022 Journal of clinical lipidology article Medicine Lipoproteins and Cardiovascular Health Open access
Patrick M. Moriarty, Philippe Gabríel Steg, Jennifer McGinniss, Andreas Michael Zeiher, Harvey Douglas White, Garen Z. Manvelian, +12 more
5citations -
Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome
J. Wouter Jukema, Nicolaas J.M. van Neer, Michael J. Szarek, Christa M. Cobbaert, Vera Bittner, Markus Schwertfeger, +8 more
2citations -
Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial
Hendrik Rüddel, Daniel O. Thomas-Rüddel, Konrad Reinhart, Friedhelm Bach, Herwig Gerlach, Matthias Lindner, +81 more
74citations -
Adverse Effects of Oxidative Stress on Bone and Vasculature in Corticosteroid-Associated Osteonecrosis: Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 in Cytoprotection
Yusuke Kubo, Wolf Drescher, Athanassios Fragoulis, Mersedeh Tohidnezhad, Holger Jahr, Matthias Gatz, +5 more
38citations -
Glycodeoxycholic Acid Inhibits Primary Bile Acid Synthesis With Minor Effects on Glucose and Lipid Homeostasis in Humans2024 The Journal of Clinical Endocrinology & Metabolism article Medicine Drug Transport and Resistance Mechanisms Open access
Emma C. E. Meessen, Soumia Majait, Steven W.M. Olde Damink, Johannes Anthonius Romijn, Jens Juul Holst, Bolette Hartmann, +6 more
11citations -
Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ 9 ‐Tetrahydrocannabinol Without Improving Its Analgesic Properties2024 Clinical Pharmacology & Therapeutics article Medicine Cannabis and Cannabinoid Research Open access
Andriy A. Gorbenko, Jules A. A. C. Heuberger, Linda E. Klumpers, Marieke L. de Kam, Pamela K. Strugala, Saco J. de Visser, +1 more
21citations -
A multidisciplinary approach to assessing the impact of local therapy in pediatric bone sarcoma patients and survivors: a cross-sectional study of adverse events and health-related quality of life
Leonie G Tigelaar, Lianne Haveman, W. Peter Bekkering, Harm van Tinteren, Heleen Maurice‐Stam, Hinke van der Hoek, +13 more
3citations -
Effects of oral semaglutide on heart failure outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease participating in SOUL trial
Rodica Pop-Busui, S Rasmussen, John Eric Deanfield, John B. Buse, Nikolaus Marx, Sharon L. Mulvagh, +9 more
3citations